EndoChoice RescueNet

Register to receive a free US Gastrointestinal Endoscopic Devices Market report synopsis and brochure

EndoChoice Holdings, Inc. (NYSE: GI) announced the full market release of its RescueNet™ retrieval device. Based upon the OmniLoop™ technology unveiled with the Boa® polypectomy snare, RescueNet’s design also incorporates new ProMesh™ technology. RescueNet™ provides greater visibility and control with improved mesh strength, which allows for reliable and efficient foreign body removal. The company is beginning sales and distribution in the United States, European Union, and other select markets.

Since its recent introduction, RescueNet™ has been extremely well received by nurses and physicians. “The RescueNet is the best on the market today. It opens and closes in any position, adjustable, and works time after time. It never seems to wear out,” stated Jerry Rayfield, GI Nurse Manager at Russell Medical Center, Alexander City, AL.

This year EndoChoice will be highlighting RescueNet™ in its booth at Digestive Disease Week (DDW®) in San Diego, California, and at the SGNA 43rd Annual Course in Seattle, Washington.

Commenting on the new product release, Mark Gilreath, Founder and CEO of EndoChoice said “This innovation is the result of our company’s unique insights into the needs of GI caregivers to provide tools which improve the efficiency and effectiveness of their clinical procedures. RescueNet™ is the perfect addition to our family of Rescue® retrieval devices and the EndoChoice® portfolio of polypectomy devices, which includes the Boa® polypectomy snare, Mako™ biopsy forceps, Neptune® injection needle, and the TrapEase® polyp trap.”

About EndoChoice
Based near Atlanta, Georgia, EndoChoice® (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy® (Fuse®) system. EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

For Further Information
More on the gastrointestinal device market in the U.S. can be found in the report published by iData entitled U.S. Market for Gastrointestinal Endoscopic Devices. This report covers the U.S. market segments for gastrointestinal endoscopic devices, capsule endoscopy, virtual colonoscopy, stenting and dilation devices, endoscopic retrograde cholangiopancreatography devices, biopsy forceps, polypectomy snares, fine aspiration needles, specimen and foreign-body removal devices, hemostasis devices, anti-reflux devices, enteral feeding devices, and Barret’s esophagus ablation devices.

The iData series on the market for gastrointestinal endoscopic devices covers the U.S., Brazil, China, Canada, India, Japan, and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at [email protected] for a U.S. Market for Gastrointestinal Endoscopic Devices report brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.


Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch